1. Home
  2. CPIX vs SPCB Comparison

CPIX vs SPCB Comparison

Compare CPIX & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • SPCB
  • Stock Information
  • Founded
  • CPIX 1999
  • SPCB 1988
  • Country
  • CPIX United States
  • SPCB Israel
  • Employees
  • CPIX N/A
  • SPCB N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • CPIX Health Care
  • SPCB Technology
  • Exchange
  • CPIX Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • CPIX 48.5M
  • SPCB 42.8M
  • IPO Year
  • CPIX 2009
  • SPCB N/A
  • Fundamental
  • Price
  • CPIX $3.31
  • SPCB $11.65
  • Analyst Decision
  • CPIX
  • SPCB Strong Buy
  • Analyst Count
  • CPIX 0
  • SPCB 1
  • Target Price
  • CPIX N/A
  • SPCB $18.00
  • AVG Volume (30 Days)
  • CPIX 29.4K
  • SPCB 89.0K
  • Earning Date
  • CPIX 11-06-2025
  • SPCB 11-13-2025
  • Dividend Yield
  • CPIX N/A
  • SPCB N/A
  • EPS Growth
  • CPIX N/A
  • SPCB N/A
  • EPS
  • CPIX N/A
  • SPCB N/A
  • Revenue
  • CPIX $42,071,813.00
  • SPCB $27,426,000.00
  • Revenue This Year
  • CPIX N/A
  • SPCB N/A
  • Revenue Next Year
  • CPIX N/A
  • SPCB $29.31
  • P/E Ratio
  • CPIX N/A
  • SPCB $15.79
  • Revenue Growth
  • CPIX 11.34
  • SPCB 2.17
  • 52 Week Low
  • CPIX $1.04
  • SPCB $2.97
  • 52 Week High
  • CPIX $7.25
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.00
  • SPCB 65.70
  • Support Level
  • CPIX $3.21
  • SPCB $9.91
  • Resistance Level
  • CPIX $3.57
  • SPCB $10.72
  • Average True Range (ATR)
  • CPIX 0.20
  • SPCB 0.65
  • MACD
  • CPIX -0.01
  • SPCB 0.23
  • Stochastic Oscillator
  • CPIX 20.83
  • SPCB 96.83

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: